Actualités

JSC Kalceks starts production and commercialization of Midazolam 5 mg/ml solution for injections. Product has been registered via decentralized registration procedure involving 9 European Union countries. First sales are expected in Latvia and Hungary following by other EU countries.

JSC “Kalceks” starts production and commercialization of Dexketoprofen 25 mg/ml 2 ml solution for injections. Product has been recently approved via decentralized registration procedure involving seven European Union countries. First sales are expected in Baltic States – Latvia, Lithuania and Estonia, where it is already available under name Dexketoprofen Kalceks, then in Poland and Bulgaria under brand name Auxilen®, as well as in Romania where it will be commercialized under brand name Xedofen®.

JSC “Kalceks” starts production and commercialization of B-vitamins complex solution for injections. The product has been recently approved via decentralized registration procedure involving ten European Union countries. First sales are expected in Baltic countries, where it is already available under brand name “Neiratax®” and in Poland, where it will be commercialized under brand name “Neiraxin® B”.

JSC “Kalceks” announces that the medicine “Tramadol-Kalceks 100mg/2ml solution for injection” has been approved by the State Agency of Medicines of the Republic of Latvia in June, this year. Active substance of the product is tramadol hydrochloride that works in certain areas of the brain and nervous system and is commonly used for treating of moderate to moderately severe pain.